Specialty Probiotics

Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer health benefits on the host. We are the pioneer of probiotics and India’s largest prescribed probiotic brand “Sporlac” has been built by our team and is in the market for more than 5 decades and is commonly used for all types of diarrhoea. Novel therapeutic applications of probiotics developed by us support CKD patients undergoing dialysis, prevent renal calculi, help manage Irritable Bowel Syndrome, Inflammatory Bowel Disease – Crohn’s disease and Ulcerative colitis, Recurrent Respiratory Infections and Allergies. All our probiotic strains have been stringently tested for safety and efficacy. Our speciality probiotic products act as supplements and drugs.

LOBUN FORTE

LOBUN is a formulation that incorporates four beneficial probiotic bacteria (NLT 45 billion): Streptococcus thermophilus, Lactobacillus acidophilus, Bacillus Coagulans (formerly known as Lactobacillus Sporogenes), and Bifidobacterium longum. Lobun Forte is a special probiotic combination with higher strength for uremic detoxification (creatinine, urea and others), acts by Enteric toxin reduction technology and for delaying the progression of Chronic Kidney Disease (CKD).

LOBUN® FORTE

LOBUN® is a formulation that incorporates four beneficial probiotic bacteria (NLT 45 billion): Streptococcus thermophilus, Lactobacillus acidophilus, Bacillus Coagulans (formerly known as Lactobacillus Sporogenes), and Bifidobacterium longum. Lobun Forte is a special probiotic combination with higher strength for uremic detoxification (creatinine, urea and others), acts by Enteric toxin reduction technology and for delaying the progression of Chronic Kidney Disease (CKD).

.

Therapeutic Uses:

Ingredients:

LOBUN®

LOBUN® is a formulation that incorporates four beneficial probiotic bacteria (NLT 15 billion): Streptococcus thermophilus, Lactobacillus acidophilus, Bacillus Coagulans (formerly known as Lactobacillus Sporogenes), and Bifidobacterium longum. Lobun® is a special probiotic combination for uremic detoxification (creatinine, urea and others), acts by Enteric toxin reduction technology and for delaying the progression of Chronic Kidney Disease (CKD).

Therapeutic Uses:

Ingredients:

OXALO FORTE

A safe symbiotic bio-therapeutic agent with NLT 5.0 billion cells of probiotics (Oxalobacter Formigenes, lactobacillus acidophilus, Bifidobacterium Lactis, Bacillus Coagulans). Oxalo Forte is a special probiotic combination with higher strength and is effective in the prevention and treatment of renal/kidney stones (Nephrolithiasis).
DISCLAIMER: †Lobun® is a trademark of Sanzyme Private Limited vide International Registration number 1728502 under Madrid Protocol, not intended for marketing and commercialization in India.

OXALO FORTE

A safe symbiotic bio-therapeutic agent with NLT 5.0 billion cells of probiotics (Oxalobacter Formigenes, lactobacillus acidophilus, Bifidobacterium Lactis, Bacillus Coagulans). Oxalo Forte is a special probiotic combination with higher strength and is effective in the prevention and treatment of renal/kidney stones (Nephrolithiasis).

.

Therapeutic Uses:

Ingredients:

OXALOTM

A safe symbiotic bio-therapeutic agent with NLT 2.5 billion cells of probiotics (Oxalobacter formigenes, Lactobacillus Acidophilus, Bifidobacterium Lactis, Bacillus Coagulans). OxaloTM is a special probiotic combination and is effective in the prevention and treatment of renal/kidney stones (Nephrolithiasis).

Therapeutic Uses:

Ingredients:

NUBACT XL

An unique combination of well studied strains of streptococcus fecalis, Clostridium Butyricum, Bacillus Mesentericus and Bacillus Coagulans is effective in the management of Non-alcoholic fatty liver disease (NAFLD), Non-alcoholic Steato Hepatosis (NASH), Inflammatory Bowel Disease – Crohn’s Disease / Ulcerative Colitis, Clostridium difficle associated Diarrhea – co-prescribed with Proton Pump Inhibitors (PPIs).
DISCLAIMER: †OXALOTM  is a trademark of Sanzyme Private Limited excluding India. This disclosure does not intend to market and commercialize OXALOTM in India but for export purposes only.

NUBACT XL

An unique combination of well studied strains of streptococcus fecalis, Clostridium Butyricum, Bacillus Mesentericus and Bacillus Coagulans is effective in the management of Non-alcoholic fatty liver disease (NAFLD), Non-alcoholic Steato Hepatosis (NASH), Inflammatory Bowel Disease – Crohn’s Disease / Ulcerative Colitis, Clostridium difficle associated Diarrhea – co-prescribed with Proton Pump Inhibitors (PPIs).

.

Therapeutic Uses:

Ingredients:

Each 0.5 g sachet contains:

SPORLAC DS

Unique and Proprietary strain of lactic acid bacillus - 120 million spores (Earlier known as Lactobacillus Sporogenes or Bacillus Coagulans) that protects the intestinal flora from the invasion of pathogens. Sporlac DS augments the action of antibiotic and also produces antimicrobial substances. Sporlac modulates intestinal flora.

Therapeutic Uses:

Available Formulations/Strengths:

SPORLAC PLUS

A diverse and unique combination of well-studied 5 probiotic strains of Lactobacillus Acidophilus, Lactobacillus Rhamnosus, Bacillus Coagulans, Bifidobacterium Longum and Saccharomyces Boulardii and is quite effective in the management of all types of Diarrhea, Bacterial vaginosis, boosting immunity, lactose intolerance and co-prescription with broad spectrum antibiotics.

SPORLAC® PLUS

A diverse and unique combination of well-studied 5 probiotic strains of Lactobacillus Acidophilus, Lactobacillus Rhamnosus, Bacillus Coagulans, Bifidobacterium Longum and Saccharomyces Boulardii and is quite effective in the management of all types of Diarrhea, Bacterial vaginosis, boosting immunity, lactose intolerance and co-prescription with broad spectrum antibiotics.

.

Therapeutic Uses:

Ingredients:

Each Sachet contains:

DISCLAIMER: †SPORLAC® is a trademark of Sanzyme Private Limited vide International Registration number 1728503 under Madrid Protocol, not intended for marketing and commercialization in India.

BACICLASI

Baciclasi is a preparation consisting of a suspension of Bacillus Clausii Spores, normal inhabitants of the intestine, with no pathogenic properties. Administered orally, Bacillus Clausii Spores, due to their high resistance to both chemical and physical agents, cross the barrier of the acid gastric juices reaching, unharmed, the intestinal tract where they are transformed into metabolically active vegetative cells.

Therapeutic Uses:

Available Formulations/Strengths:

SOLIB

SOLIB – Saccharomyces Boulardii works by restoring the balance of good bacteria in the intestine that may get upset after antibiotic use or due to intestinal infections.
250 mg of Saccharomyces Boulardii – Sachets and Capsules

SOLIB

SOLIB – Saccharomyces Boulardii works by restoring the balance of good bacteria in the intestine that may get upset after antibiotic use or due to intestinal infections.
250 mg of Saccharomyces Boulardii – Sachets and Capsules

.

Therapeutic Uses:

Visited 1,440 times, 11 visit(s) today
Close Search Window